FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    33081000077110 un fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    un Is a General adjectival modifier false Inferred relationship Some
    un Is a nombre false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely pizotifen 50 microgram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Glucose 40 mg/mL and sodium chloride 1.8 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Glucose 40 mg/mL and sodium chloride 1.8 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 2
    Product containing precisely didanosine 1.67 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely didanosine 1.67 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Hydromorphone hydrochloride 4 mg/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Hydromorphone hydrochloride 4 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely sumatriptan 10 milligram/1 actuation conventional release nasal spray (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Adrenaline 1 mg/mL eye solution Has concentration strength numerator value False un Inferred relationship Some 1
    Adrenaline 1 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 1
    Adrenaline 1 mg/mL eye solution Count of base of active ingredient False un Inferred relationship Some
    Glucose 50 mg/mL and sodium chloride 1.8 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Glucose 50 mg/mL and sodium chloride 1.8 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 2
    Product containing precisely didanosine 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely didanosine 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely acetylcholine chloride 10 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely acetylcholine chloride 10 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Salicylic acid 170 mg/mL cutaneous solution Has concentration strength denominator value False un Inferred relationship Some 1
    Salicylic acid 170 mg/mL cutaneous solution Count of base of active ingredient False un Inferred relationship Some
    Rabbit anti-human T-lymphocyte globulin 25 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
    Rabbit anti-human T-lymphocyte globulin 25 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
    Adrenaline 2.5 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 1
    Adrenaline 2.5 mg/mL eye solution Count of base of active ingredient False un Inferred relationship Some
    Diazepam 5 mg/mL suspension for injection Count of base of active ingredient False un Inferred relationship Some
    Diazepam 5 mg/mL suspension for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely rasburicase 7.5 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely rasburicase 7.5 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Adrenaline 10 microgram/mL and lidocaine hydrochloride 10 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Adrenaline 10 microgram/mL and lidocaine hydrochloride 10 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 2
    Hydrocodone bitartrate 500 microgram/mL and paracetamol 21.7 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 2
    Hydrocodone bitartrate 500 microgram/mL and paracetamol 21.7 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
    Ecothiopate (as ecothiopate iodide) 1.25 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 1
    Ecothiopate (as ecothiopate iodide) 1.25 mg/mL eye solution Count of base of active ingredient False un Inferred relationship Some
    Rivastigmine 192 microgram/hour prolonged-release transdermal patch Has concentration strength denominator value False un Inferred relationship Some 1
    Rivastigmine 192 microgram/hour prolonged-release transdermal patch Count of base of active ingredient False un Inferred relationship Some
    Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 2
    Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely etidocaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely etidocaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely hydrocodone bitartrate 333 microgram/1 milliliter and paracetamol 33.3 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely hydrocodone bitartrate 333 microgram/1 milliliter and paracetamol 33.3 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
    Dextromethorphan 7.5 mg oromucosal lozenge Has presentation strength denominator value False un Inferred relationship Some 1
    Dextromethorphan 7.5 mg oromucosal lozenge Count of base of active ingredient False un Inferred relationship Some
    Paracetamol 32 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
    Paracetamol 32 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
    Hetastarch 60 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Hetastarch 60 mg/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Rivastigmine 396 microgram/hour prolonged-release transdermal patch Count of base of active ingredient False un Inferred relationship Some
    Rivastigmine 396 microgram/hour prolonged-release transdermal patch Has concentration strength denominator value False un Inferred relationship Some 1
    Adrenaline (as adrenaline acid tartrate) 1 mg/mL and guanethidine 5 mg/mL eye solution Has concentration strength numerator value False un Inferred relationship Some 1
    Adrenaline (as adrenaline acid tartrate) 1 mg/mL and guanethidine 5 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 1
    Adrenaline (as adrenaline acid tartrate) 1 mg/mL and guanethidine 5 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 2
    Vardenafil (as vardenafil hydrochloride) 10 mg orodispersible tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Vardenafil (as vardenafil hydrochloride) 10 mg orodispersible tablet Count of base of active ingredient False un Inferred relationship Some
    Methoxsalen 20 microgram/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Methoxsalen 20 microgram/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely hydrocodone bitartrate 500 microgram/1 milliliter and paracetamol 33.3 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
    Product containing precisely hydrocodone bitartrate 500 microgram/1 milliliter and paracetamol 33.3 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Methylcellulose 10 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 1
    Methylcellulose 10 mg/mL eye solution Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely sodium picosulfate 66.7 microgram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely sodium picosulfate 66.7 microgram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Levoleucovorin (as levoleucovorin calcium) 50 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
    Levoleucovorin (as levoleucovorin calcium) 50 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
    Adrenaline (as adrenaline acid tartrate) 5 mg/mL and guanethidine 10 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 1
    Adrenaline (as adrenaline acid tartrate) 5 mg/mL and guanethidine 10 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 2
    Aripiprazole 7.5 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Aripiprazole 7.5 mg/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely ferrous sulfate 116 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely ferrous sulfate 116 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely sodium nitroprusside 25 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely sodium nitroprusside 25 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely prilocaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely prilocaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Somatropin 10 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Somatropin 10 mg/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and etidocaine hydrochloride 15 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2
    Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and etidocaine hydrochloride 15 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely enfuvirtide 90 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely enfuvirtide 90 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Hyoscine (as hyoscine hydrobromide) 1.25 mg/mL eye solution Has concentration strength denominator value False un Inferred relationship Some 1
    Hyoscine (as hyoscine hydrobromide) 1.25 mg/mL eye solution Count of base of active ingredient False un Inferred relationship Some
    Piroxicam 10 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Piroxicam 10 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely paracetamol 16 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely paracetamol 16 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely morphine sulfate 10 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely morphine sulfate 10 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Somatropin 4 mg/mL solution for injection Count of base of active ingredient False un Inferred relationship Some
    Somatropin 4 mg/mL solution for injection Has concentration strength denominator value False un Inferred relationship Some 1
    Levobetaxolol 5 mg/mL eye suspension Has concentration strength denominator value False un Inferred relationship Some 1
    Levobetaxolol 5 mg/mL eye suspension Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely cefpodoxime 10 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely cefpodoxime 10 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely scopolamine (as scopolamine hydrobromide) 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely scopolamine (as scopolamine hydrobromide) 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Morphine sulfate 100 mg rectal suppository Has presentation strength denominator value False un Inferred relationship Some 1
    Morphine sulfate 100 mg rectal suppository Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely zoledronic acid 50 microgram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely zoledronic acid 50 microgram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 2

    Start Previous Page 195 of 215 Next End


    Reference Sets

    Concept inactivation indicator reference set

    Back to Start